Scientific presentations, webinars and posters

A selection of presentations from SomaLogic scientists and their collaborators.

POSTER: Erik Zimmerman, Ashley East, Samantha Peters, Sheri Wilcox and Nebojsa Janjic
SOMAmer®Reagents: A New Class of Protein Binding Reagents

WEBINAR: N Janjic and D Zichi
The Exquisite Specificity of SOMAmer Reagents – A New Type of Protein Affinity Binding Reagent

WEBINAR: S Williams and R Gerszten
Integrating Metabolomic and Proteomic Profiles for 'Less Impersonal' Medicine

WEBINAR: A Clayton and S Williams
Probing Exosomes Using Novel Affinity-Based Proteomic Technology

WEBINAR: N Janjic and D Davies
Bound for success: Powerful new affinity reagents for multiple applications

WEBINAR: R Lee and J Swindle
Pharmacology and Pathology: SOMAscan Hunting

WEBINAR: S Williams
The Art, Science, and Discipline of Biomarker Study and Program Design

WEBINAR: G Baird, R Brand, H Pass
Case Studies in Protein Biomarker Discovery and Validation for Oncology

WEBINAR: R Ostroff, S Williams and N Saccomano
Proteomics of Pulmonary Diseases

WEBINAR: S Williams and N Saccomano
Unlocking protein biomarker discovery for pharma, biotech and academia (free, but registration required)

POSTER: SK Wilcox et al.
SOMAscanTM Assay: A proteomic platform that can also detect SNPs

POSTER: DR Davies et al.
SOMAmers: Defining a new structural vocabulary with modified nucleotide DNA aptamers in complex with protein targets

POSTER: MP Nikrad et al.
Novel Serum Protein Signature Associated with Non-Alcoholic Fatty Liver Disease

POSTER: MP Nikrad et al.
Identification of Prognostic Biomarkers of Chronic Obstructive Pulmonary Disease (COPD) Using a Multiplex SOMAmer™ Assay

POSTER: SK Nelson et al.
A study of protein changes in Duchenne Muscular Dystrophy using SOMAscan multiplex proteomic technology

POSTER: D Ayers et al. 
Differential protein signatures in erlotinib-sensitive and resistant lung cancer cell lines in vitro and in vivo

POSTER: SK Nelson et al.
Discovery of neurological biomarker signatures using SOMAscan multiplex proteomic technology

POSTER: B Mehler et al.
How one thousand proteins in almost 1000 subjects can help us stratify cardiovascular risk

POSTER: B Lollo et al.
SOMAscan™: A Quantitative Multiplex Proteomic Platform that Measures 1129 Analytes in Complex Matrices

POSTER: S Williams et al.
Exposing the criminal record of every blood sample: Use of SOMAmer technology and sample mapping vectors to mitigate false biomarker discoveries.

POSTER: R Gill et al.
Proteomic insights in oncology: What have we learned from measuring millions of proteins?

POSTER: N Finkel et al.
Protein Profiling Comparison of Modified DNA Aptamer Screening to Data Dependent Mass Spectrometry across Cancer Cell Lines